Background and Aim: Understanding of cellular and molecular mechanisms involved in cell/tumor growth and progression has led to molecular-targeted therapy. HER1 and HER2 are two main oncogenic components of HER-receptor family considered as targets for cancer research and therapy. Reliable results of HER-related research and targeted therapies dependent upon cell line with known HER expression status. But there are no published studies focusing on determination of HER1 and HER2 receptors expression in CHO and HEK-293 cell lines. Methods: Absolute expressions of HER1 and HER2 in CHO, HEK-293, MDA-MB-468 and SKBR3 cells were evaluated using quantitative real-time PCR. Absolute expression quantification was carried out by serial dilution plasmids harboring HER1 and HER2 to extrapolate standard curve. Results: Real-time PCR amplification was successfully optimized by HER1 and HER2 plasmids with high efficiency and their copy numbers were calculated. The results showed that HER1 was not expressed in CHO and HEK-293 cells but these cells express HER2 up to 9.4 × 10 2 and 1.1 × 10 5 copy/µg, respectively. MDA-MB-468 and SKBR3 cells express HER1 up to 8.4 × 10 5 and 9.7 × 10 4 , respectively. In addition, the expression of HER2 is higher on the surface of SKBR3 cell (6.5 × 10 6 copy/µg).
Introduction
Human epidermal growth factor receptors (HER) play an important role in proliferation, migration, angiogenesis, and resistance to apoptosis in many cancers (1) . HER family is a tyrosine kinase family including four homologous members: HER1, HER2, HER3 and HER4. They share common structure consist of: an extracellular ligand binding domain, a transmembrane domain, and an intracellular tyrosine kinase domain (2, 3) . The activation of HER receptor depends on ligand binding, dimerization and phosphorylation of downstream adaptor/proteins. HER1 proto-oncogene encodes a 170 kDa transmembrane glycoprotein related not only to breast carcinogenesis (4) but also in colorectal, gastric, glioblastoma, non-small cell lung, head and neck and ovarian cancers (5) . Proto-oncogene HER2/neu encodes a 180 kDa tyrosine kinase receptor related to wide variety of human cancers (6, 7) . Ligand binding promotes HER receptors homo and hetero dimerization and leads to receptors activation, subsequently their signaling pathway, Ras/ Raf/ MEK/ ERK and PI3K/ Akt, are triggered. These downstream signaling pathways resulted in cell/tumor growth and metastasis (8) . Inhibition of HER1 and HER2 by anti-HER agents can down regulate HER-overexpressing cancers (9) . According to the potential of these receptors in pathogenesis of a
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Hosseinzadeh Colagar et al. rmm.mazums.ac.ir Res Mol Med, 2013; 1 (3): 7 large number of human cancers, these receptors were considered as promising targets for cancer treatment (10) . Cell lines are indefinite sources of homogenous cell population, manifesting their original properties. Human embryonic kidney cells (HEK)-293 is the most common cell line for rapid production and large scale transient expression of recombinant protein (11) . Chinese hamster ovary cells (CHO) is a standard expression system with efficient post translational modification for recombinants therapeutic products (12) . Therefore, these cell lines are proper model system for biopharmaceutical products targeting HER family in cancer study. Reliable results of HER-targeted therapies dependent upon cell line with known HER expression status. But, there are no published studies focusing on determination of HER1 and HER2 receptors expression in CHO and HEK-293 cell lines. Immunobloting analysis done by Shi et al (13) implied no EGFR or HER1 expression, while others (14) mentioned low or undetectable expression level of ErbB receptor in CHO cells. In the same way, HER1 and HER2 expression in HEK-293 cells are controversial in different analysis such as Lanteri et al (15) and Xu et al (16) . The present study investigated the precise endogenous expression levels of HER1 and HER2 receptors in CHO and HEK-293 cells.
Materials and Methods
Cell culture CHO, HEK-293, SKBR3 (HER2 positive control), and MDA-MB-468 (HER1 positive control) cell lines were purchased from Pasteur Institute, Iran. The cells were grown in suspension culture at 37 °C under 5% humidified CO 2 in bioactive medium RPMI 1640 (PAA, Pasching/ Austria) containing inactivated fetal bovine serum (PAA, Pasching/ Austria), L-glutamine (300mg/l), penicillin (100 U/ mL), and streptomycin (100µg/ml). The experiments were carried out at cell densities of 3 × 10 6 cells per milliliter.
RNA isolation and cDNA synthesis
The total RNA was isolated from 80% confluent cultured cells by RNeasy Mini Kit (Qiagen, Germany) according to manufactures' instructions. Finally, RNA pellet dissolved in DEPC-treated water. Concentration and quality of RNA was checked by the absorbance values at 260 nm, A 260/280 and A 260/230 ratio and confirmed by electrophoresis in 1% agarose gel. Total RNA (1µg) was subjected to single strand cDNA synthesis using a cDNA synthesis kit (Parstous, Mashhad/ Iran). Briefly, cDNA synthesis was carried out using 200 U MMLV RTase, 2mM dNTP mixture and 200 ng/µl random hexamer in a total volume 20 µl reaction containing: 10 µl 2X RT Premix, 2 µl random hexamer, 1 µg RNA template and 7 µl DEPC-treated water.
Quantitative real time PCR Her1 or Her2 gene expression was determined by quantitative real-time polymerase chain reaction (qRT-PCR) using DNA Mastermix SYBR Premix Ex Taq II (Takara, Japan) on an iCycler iQ5 real-time PCR machine (BioRAD, USA). The gene sequences of Her1 and Her2 were derived from the NCBI National Center for Biotechnology Information (NCBI) and primers were designed using Allele ID 7.5 software (Table1). The final reaction volume for Her1 was 20 µl which contains: 10 µl Mastermix SYBR Green II (Takara, Japan), 333 pmol forward primer, 285 pmol reverse primer, 2 µl cDNA and 6.7 µl distilled water. Her2 amplification was carried out in 20 µl reaction including: 10 µl Mastermix SYBR Green II (Takara, Japan), 285 pmol forward primer, 333 pmol reverse primer, 2 µl cDNA and 6.7 µl distilled water. Her1 gene amplified in 40 cycles including; 95 ˚C for 3 min, 95 ˚C for 10 sec, 62.7 ˚C for 30 sec and 72 ˚C for 30 sec and a final extension for 5 min at 72 ˚C, followed by a standard melting curve analysis. Amplification of Her2 is similar to Her1 except annealing temperature that is 62 ˚C in 30 sec. Absolute quantification was performed by comparing the threshold cycle values (C T ) for the samples, with standard curves generated with HER1 and HER2 plasmid DNA.
Plasmid preparation
To determine the absolute copy number of the receptors; HER1 and HER2 plasmids and 
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Absolute quantitative assay
To evaluate absolute quantitative gene expression, HER1 and HER2 plasmids (Sino biological, China) were used. Serially diluted standards of HER1 and HER2 plasmids with known concentration were used to produce a standard curve. The standard curve revealed a linear relationship between C T and initial amount of total RNA or cDNA, so the concentrations were interpolated from standard curves on the basis of C T values (17) . Six 10-fold dilutions of HER1 plasmid and eight 10-fold dilutions of HER2 plasmid were prepared for plotting standard curve ( Figure 1) . The real-time PCR procedures included appropriate positive and negative controls.
Results
RNA quality of cell lines was evaluated on a 1% agarose gel electrophoresis. The concentration and purity of the RNA was described by the mean A 260/280 and A 260/230 ratio and were on average 1.83 and 1.89, respectively. RNA isolation was performed from trypsinized cells and 1 µg RNA was reverse transcribed to cDNA. Gene copy numbers were calculated by absolute realtime PCR using serially diluted plasmids as standards. For quality control all RNA isolation and cDNA synthesis carried out two times. The standard curves were analyzed for two properties, the coefficient of correlation (R 2 ) and amplification efficiency (E) derived from the slope of standard curve. The standard curves for HER1 ranging from 2.88 × 10 9 to 2.88 × 10 4 copies and HER2 ranging from 2.5 × 10 9 to 2.5 × 10 2 copies are shown in Figure 1 . The copy numbers of plasmid DNA were calculated using the online calculator provided by the URI Genomics & Sequencing Center (18). The formula used is: (amount × 6.022×10 23 ) / (length × 1×10 9 × 650), in which amount, is concentration of plasmid in nanogram/microliter, 6.022×10 23 (molecule/mole) is Avogadro's number, length, is full length of plasmid in base pair, 650 (gram/mole) is the average molecular weight of a base pair and 1×10 9 is used for conversion gram to nanogram. Copy numbers were calculated for 30 nanogram (ng) of HER1 and HER2 plasmid DNA. Both curves were linear in the range tested (R 2 > 0.99) by the duplicate reactions. The slopes of the standard curves for HER1 and HER2 were -3.5 and -3.4, respectively. From the slopes, high amplification efficiencies of 0.91 and 0.96 were determined for HER1 and HER2 in the tested range. Our qPCR assay is optimized accurately regarding to R 2 > 0.99 showing linear standard curve and efficiency equal to 90-105 representing high amplification efficiency. Therefore, absolute copy numbers of HER1 and HER2 in each cell lines were calculated based on its C T value with its plasmid DNA standard curve. The copy numbers of HER1 and HER2 receptors were shown in Table 2 .
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Discussion
Precise gene expression profiling by quantitative realtime PCR assay is used to determine HER1 and HER2 expression in CHO and HEK-293 cells. The results demonstrated no endogenous HER1 expression and low level of HER2 expression in these cells. Real-time qPCR provides a fast and reliable technology for gene expression quantification (19) . This sensitive method applies in two convenient ways: absolute and relative. Absolute qPCR assay allows detecting target gene copy numbers based on the standard curve. Plasmid DNA is often used as an external standard for generating standard curve. As previous studies have confirmed that linear plasmids are more reliable for copy number estimation (20) , Pvu I-linearized HER1 and HER2 plasmids were used to measure copy numbers. After ampicillin resistance screening and plasmid purification, these plasmids are brought to create standard curves. The copy numbers of samples were calculated following the qPCR optimizing. Our study showed no Her1 amplification in CHO and HEK-293 while HER2 levels were 9.4 × 10 2 copy/µg RNA of CHO and 1.13 × 10 5 copy/µg RNA of HEK-293, as shown in Table 2 . Table 2 . HER1 and HER2 expression in the most common cell lines *The copy number of each cell line was calculated in regard to its CT and known copy number of HER1 and HER2 plasmids.
According to our results, CHO and HEK-293 don't express HER1 but they express low level of HER2. Determining HER1 and HER2 expression profiling of CHO and HEK-293 is consequential for many researches. Different results have been reported by Tzahara et al (21) , Krug et al (22) , Hatakeyama et al (14) and others about HER1 and HER2 expression in CHO. The contradictory results of HER1 and HER2 expression have been reported in HEK-293 ( Table 3 ).
The main finding of this study is confirmation and extension previous knowledge about HER1 and HER2 expression by an accurate, sensitive, and fast method. High levels expression of HER1 (8.4 × 10 5 copy/µg) in MDA-MB-468 and HER2 (6.5622 × 10 6 copy/µg) in SKBR3 in our study are concordance to previous studies which reported that MDA-MB-468 and SKBR3 highly expressed HER1 and HER2, respectively (23) (24) (25) (26) (27) (28) . While HER2 expression has not been detected in different studies (29, 30) , our results showed that MDA-MB-468 expressed HER2 as much as 1.5 × 10 4 copy/µg. In addition, SKBR3 cells expressed HER1 up to 9.7 × 10 4 copy/µg. In other words, real time PCR is a highly sensitive and accurate method for determining the precise expression of HER1 and HER2 on the cell surface.
HER1 and HER2 activation initiate potent signaling pathways resulted in many key cellular functions, including cell growth, division, migration, adhesion, angiogenesis, and apoptosis (31) . These receptors are involved in the pathogenesis of variety of human cancers such as breast, ovarian, bladder, glioblastoma, gastric, lung, and pancreas (6, 7) . Since HER1 and HER2 expression profile is a crucial determinant in cancer pathogenesis and cancer related studies, these two main oncogenic components of HER-receptor family considered as targets for biological researches and cancer therapy. Heterologous expression studies are principle part of biological and biomedical researches for analyzing interaction between receptors and their mutations. These studies must be evaluated on cell lines as reliable system model for validation. In addition, many cancer-related studies such as targeted therapy and drug screening require to right control cell lines. Knowing the precise expression levels of these receptors on cell surface is a fundamental need in the development of any HER-related study. In the present study, CHO and HEK-293 cells were selected as two most applicable cells used in biomedical and biological studies. Quantitative realtime PCR was performed in order to measure HER1 and HER2 expression levels in these cells. HER1 and HER2 expression analysis in these cell lines revealed no copies of HER1 while low copy numbers of HER2 receptor were measured. This is the agreement with the finding of some previous studies used immunoprecipitation, blotting, and other methods and imply HER1 and HER2 expression pattern in CHO and HEK-293 cells. HER1 and HER2 are linked to development of many cancers; therefore, they are key targets in functional studies. Such researches need to powerful experimental tools to achieve accurate results. The popularity of cell lines is largely due to their top feathers, making them an ideal model for many biomedical researches especially cancer relatedstudies. The choice of cell line as an in vitro model is the first and important step in cancer research. This indicates the need for more attempts to consider molecular profiles of cell lines. Taken to gather, this is the first study that quantitatively report HER1 and HER2 expression in CHO and HEK-293 cells. These results provide an important insight to consider HER1 and HER2 expression pattern even in low level for basic and applied studies. Our interest lies in describing right cell lines especially for heterologous expression studies. With respect to data derived from absolute real-time PCR, we suggest that CHO and HEK-293 are proper cell lines for HER1-related heterologous study while low endogenous expression level of HER2 made these cells suitable for HER receptorrelated research.
